Clinical and bone marrow effects of α-interferon therapy in myelofibrosis with myeloid metaplasia.

被引：0
|
作者：
Tefferi, A [1 ]
Elliott, MA [1 ]
Yoon, SY [1 ]
Li, CY [1 ]
Mesa, RA [1 ]
Call, TG [1 ]
Dispenzieri, A [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3222
引用
收藏
页码：745A / 745A
页数：1
相关论文
共 50 条
  • [21] A combination of low dose thalidomide with prednisone in myelofibrosis with myeloid metaplasia.
    Mesa, RA
    Li, CY
    Steensma, DP
    Pardanani, A
    Elliott, MA
    Kaufmann, SH
    Gray, L
    Schroeder, GS
    Tefferi, A
    BLOOD, 2002, 100 (11) : 71A - 71A
  • [22] Multiple courses of splenic irradiation in patients with myelofibrosis with myeloid metaplasia.
    Zelig, O
    Tochner, Z
    Weshler, Z
    Rachmilewitz, EA
    BLOOD, 1999, 94 (10) : 293B - 293B
  • [23] Myelofibrosis complicating Polycythemia vera is cytogenetically different from "primary" Myelofibrosis with Myeloid Metaplasia.
    Andrieux, J
    Laï, JL
    Dupriez, B
    Caulier, MT
    Bauters, F
    Rose, C
    Agape, P
    Demory, JL
    BLOOD, 2002, 100 (11) : 588A - 588A
  • [24] BONE-MARROW CHANGES IN MYELOFIBROSIS WITH MYELOID METAPLASIA - A SEQUENTIAL STUDY
    WOLF, BC
    NEIMAN, RS
    LABORATORY INVESTIGATION, 1983, 48 (01) : A95 - A95
  • [25] Myelofibrosis with myeloid metaplasia with fatty bone marrow: report of a new case
    Gerli, GC
    Gianelli, U
    Carraro, MC
    Bestetti, A
    Marchetti, M
    Barosi, G
    HAEMATOLOGICA, 2001, 86 (08) : 885 - 886
  • [26] Clinical relevance of the number of circulating CD34-positive cells in myelofibrosis with myeloid metaplasia.
    Barosi, G
    Viarengo, G
    Rosti, V
    Piaggio, G
    Marchetti, M
    Frassoni, F
    BLOOD, 2000, 96 (11) : 744A - 745A
  • [27] INDUCTION AND MAINTENANCE ALPHA-INTERFERON THERAPY IN MYELOFIBROSIS WITH MYELOID METAPLASIA
    BAROSI, G
    LIBERATO, LN
    COSTA, A
    BURATTI, A
    DIDIO, F
    SALVATORE, S
    ASCARI, E
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1990, 45 : 12 - 14
  • [28] Both B and T lymphocytes are clonally involved in myelofibrosis with myeloid metaplasia.
    Reeder, TL
    Bailey, RJ
    Dewald, GW
    Tefferi, A
    BLOOD, 2002, 100 (11) : 588A - 588A
  • [29] Unrelated hematopoietic stem cell transplantation (HSCT) for myelofibrosis with myeloid metaplasia.
    Koldehoff, M
    Basara, N
    Kiehl, MM
    Fauser, AA
    BLOOD, 2001, 98 (11) : 385B - 385B
  • [30] RARβ2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia.
    Jones, LC
    Tefferi, A
    Idos, GE
    Hofmann, WK
    Kumagai, T
    Koeffler, HP
    BLOOD, 2002, 100 (11) : 587A - 587A
12345